🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 29014R301 (prev. 29014R103 )
- Market Cap
- Mid Cap
- IPO
- 4/26/2018 · $9.75/share
- Previous Symbol
- ELOXD (changed 6/9/2026)
Business: Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases.
Company Contact
- CEO
- Sumit Aggarwal
- CFO
- Daniel E. Geffken
- Headquarters
- 10 Court Street, Arlington, MA 02476
- Phone
- 781-577-5300
- Investor Relations
- John Woolford · 443-213-0506 · ir@eloxxpharma.com